Computer chips, servers and cooling system in this mega-data center will consume as much energy as 120,000 and 270,000 homes for a year. About 85% of the power will come from liquid natural gas ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

is transportation editor with 10+ years of experience who covers EVs, public transportation, and aviation. His work has appeared in The New York Daily News and City & State. On Monday, Elon Musk ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Data Privacy Day asks us to be more aware. The harder ...

At least 25 data center projects around the country were canceled last year due to opposition from the local communities, according to research from intelligence platform Heatmap Pro. The canceled ...

Hyperscale data centers are now powering AI models with a revolutionary architecture—at a staggering energy cost. In sprawling stretches of farmland and industrial parks, supersized buildings packed ...

The ACE Basin is a nationally known nature preserve that is considered a model of public-private conservation efforts. It lies in eastern South Carolina. Photo courtesy The Nature Conservancy ...

Microsoft said it's interested in building a data center on a site beside a federal highway outside Grand Rapids, Michigan. In December, planning officials postponed a hearing on the development after ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...

The two demo satellites that Google and Planet are developing for Project Suncatcher are versions of Planet’s new Owl line of imaging satellites. Credit: Planet WASHINGTON — Planet, a company best ...

The last time I wrote an article on Structure Therapeutics Inc. (GPCR) it was in a Seeking Alpha article entitled "Structure Therapeutics: Potential To Have Best-In-class GLP-1 Agonist For Obesity ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...